|
101
|
|
|
Sphingomyelin phosphodiesterase acid like 3A |
ASM3A, ASML3a, yR36GH4.1 |
|
|
102
|
|
|
StAR related lipid transfer domain containing 3 |
CAB1, MLN64, es64 |
|
|
103
|
|
|
Serine incorporator 3 |
AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 |
|
|
104
|
|
|
Stress induced phosphoprotein 1 |
HEL-S-94n, HOP, IEF-SSP-3521, P60, STI1, STI1L |
|
|
105
|
|
|
Solute carrier family 38 member 3 |
DEE102, G17, NAT1, SN1, SNAT3 |
|
|
106
|
|
|
Splicing factor 3b subunit 2 |
CFM, Cus1, HFM, SAP145, SF3B145, SF3b1, SF3b150 |
|
|
107
|
|
|
Solute carrier family 27 member 5 |
ACSB, ACSVL6, BACS, BAL, FACVL3, FATP-5, FATP5, VLACSR, VLCS-H2, VLCSH2 |
|
|
108
|
|
|
Solute carrier family 27 member 4 |
ACSVL4, FATP4, IPS |
|
|
109
|
|
|
Solute carrier family 27 member 2 |
ACSVL1, FACVL1, FATP2, HsT17226, VLACS, VLCS, hFACVL1 |
|
|
110
|
|
|
Serine peptidase inhibitor Kazal type 5 |
LEKTI, LETKI, NETS, NS, VAKTI |
Acanthosis nigricans, Allergic rhinitis, Asthma, Clastothrix, Congenital nonbullous ichthyosiform erythroderma, Developmental delay, Dwarfism, Ectopic kidney, Eczema, Exfoliative dermatitis, Hydronephrosis, Hypereosinophilia, Ige responsiveness, atopic, Malabsorption syndrome, Mental retardation, Netherton syndrome, Parakeratosis, Prostatic neoplasms, Prostate cancer, UrticariaView all (5 more) |
